Supriya Lifescience gains ANVISA nod for Esketamine Hydrochloride & files patent for… EP News Bureau Dec 10, 2024 Supriya Lifescience has developed a technique for low-cost manufacturing of Atorvastatin
Budget 2024-25 prioritises R&D, education and business for MSMEs EP News Bureau Jul 24, 2024 Industry stakeholders appreciate the efforts made towards increasing employment, skill-building and implementation of various…
Pharma industry experts eye budget boost for innovation and global ambitions EP News Bureau Jul 8, 2024 In anticipation of the upcoming Union Budget on July 23 2024, India's $50 billion pharmaceutical industry is seeking a…
Pharma will be a major contributor to India’s economy: Dr Satish Wagh, Chairman & MD,… EP News Bureau Mar 28, 2024 Dr. Satish Wagh, Chairman & MD, Supriya Lifescience speaks to Express Pharma on the company's strategy to achieve a…
Supriya Lifescience gets GMP certification from ANVISA Brazil EP News Bureau Jan 9, 2024 ANVISA certification will help Supriya Lifescience to strategically grow its footprint in the Brazilian pharmaceutical sector and…
Supriya Lifescience, Plasma Nutrition to collaborate for protein technology EP News Bureau Aug 2, 2023 During the term of the agreement, Supriya Lifescience will lead the manufacturing and marketing of ioProtein in India
Supriya Lifescience IPO to open on 16th December EP News Bureau Dec 13, 2021 The price band of the offer has been fixed at Rs 265 to Rs 274 per equity share. Bids can be made for a minimum of 54 equity…